Skip to content

LBRX LBRX Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-$2.48M-1,382%
Alto Neuroscience logo
Alto NeuroscienceANRO
$4.13M+144%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$2.05M-618%
Opko Health logo
Opko HealthOPK
-$6.97M-155%
Septerna, Inc. logo
Septerna, Inc.SEPN
$294K-39.8%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$814K-199%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$888.98M+163%
Enterprise value$571.77M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's increase (decrease) in prepaid expense and other assets?
LBRX (LBRX) reported increase (decrease) in prepaid expense and other assets of $10.22M in Q1 2026.
How has LBRX's increase (decrease) in prepaid expense and other assets changed year-over-year?
LBRX's increase (decrease) in prepaid expense and other assets increased by 12412.0% year-over-year, from -$83K to $10.22M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.